AB
KYMR icon

Amalgamated Bank’s Kymera Therapeutics KYMR Stock Holding History

Amalgamated Bank’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,772
Closed -$138K – 2261
2025
Q4 		$138K Buy
1,772
+146
+9% +$9.86K ﹤0.01% 1649
2025
Q3 		$92K Hold
1,626
– – ﹤0.01% 1715
2025
Q2 		$71K Hold
1,626
– – ﹤0.01% 1758
2025
Q1 		$45K Buy
1,626
+233
+17% +$8.49K ﹤0.01% 1816
2024
Q4 		$56K Hold
1,393
– – ﹤0.01% 1809
2024
Q3 		$66K Hold
1,393
– – ﹤0.01% 1776
2024
Q2 		$42K Buy
1,393
+68
+5% +$2.35K ﹤0.01% 1896
2024
Q1 		$53K Sell
1,325
-4,099
-76% -$147K ﹤0.01% 1853
2023
Q4 		$138K Sell
5,424
-394
-7% -$7.05K ﹤0.01% 1904
2023
Q3 		$81K Hold
5,818
– – ﹤0.01% 2072
2023
Q2 		$134K Buy
5,818
+1,889
+48% +$54.1K ﹤0.01% 1969
2023
Q1 		$116K Sell
3,929
-923
-19% -$29.8K ﹤0.01% 1996
2022
Q4 		$121K Hold
4,852
– – ﹤0.01% 2060
2022
Q3 		$106K Buy
4,852
+48
+1% +$1.26K ﹤0.01% 2125
2022
Q2 		$95K Sell
4,804
-798
-14% -$18.6K ﹤0.01% 2183
2022
Q1 		$237K Sell
5,602
-436
-7% -$18.4K ﹤0.01% 1873
2021
Q4 		$383K Sell
6,038
-79
-1% -$4.6K ﹤0.01% 1704
2021
Q3 		$359K Buy
6,117
+657
+12% +$38.1K ﹤0.01% 1758
2021
Q2 		$265K Buy
+5,460
New +$237K ﹤0.01% 1937

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Amalgamated Bank's KYMR Position: Q1 2026 in Review

Amalgamated Bank sold out of Kymera Therapeutics (KYMR) in Q1 2026, closing a stake of 1,772 shares — an estimated $138K sold.

Amalgamated Bank first reported a position in KYMR in Q2 2021 and held it in 19 quarters. The position peaked at $383K in Q4 2021. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Amalgamated Bank reported no remaining Kymera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,772 Kymera Therapeutics shares in Q1 2026, an estimated $138K.
  • Amalgamated Bank first reported a position in Kymera Therapeutics in Q2 2021 and held it in 19 quarters.
  • Amalgamated Bank's Kymera Therapeutics position peaked at $383K in Q4 2021.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.